Advancing the Field of Pharmacotherapy for Obesity: What have the STEP Trials Taught Us? (Recorded Webinar)
CME/CE Expiration Date: 7/14/2024*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
The Semaglutide Treatment Effect in People with Obesity (STEP) Trials have been described as a game changer for obesity treatment. In this webinar Dr. Kushner will review the efficacy and safety outcomes of the four STEP trials and their importance for obesity patient care.
The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Obesity Medicine Association designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|Access Date||Quiz Result||Score||Actions|